TGFB1 and Miyoshi myopathy: Neutralizing TGF-β1 and the administration of STING agonist were able to counteract the effect of Tregs on MHC I molecule downregulation in MM cells, as well as suppressing the pro-tumorigenic effect of Tregs on MM cells in mouse model.